NCT06849206 is a clinical trial in Obesity Prevention, sponsored by Pennington Biomedical Research Center.

Who is sponsoring NCT06849206?

NCT06849206 is sponsored by Pennington Biomedical Research Center.

What condition does NCT06849206 study?

NCT06849206 studies Obesity Prevention.

Is NCT06849206 still recruiting?

NCT06849206 is currently recruiting now. Last updated 17 March 2025.

Last reviewed 2025-03-17 · How we verify

NCT06849206

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pennington Generation Cohort

Recruiting now Last updated 17 March 2025

What this trial tests

trial in Obesity Prevention in 3,000 participants. Currently enrolling.

Timeline

24 February 2025

Primary endpoint
24 February 2045

24 February 2045

Quick facts

Lead sponsor	Pennington Biomedical Research Center
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	3,000
Start date	24 February 2025
Primary completion	24 February 2045
Estimated completion	24 February 2045
Sites	1 location across United States

Conditions studied

Obesity Prevention — all drugs for Obesity Prevention →

Sponsor

Pennington Biomedical Research Center — full company profile →

Who can join

Eligibility, any sex, with Obesity Prevention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Pennington Generation Cohort is an observational study comprised of Louisiana families. Families will be assessed at baseline for a variety of traits and behaviors, and then followed up over time to try to understand the role of lifestyle and the environment on the risk of developing obesity and other health outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Obesity Prevention

Currently open trials in the same condition.

NCT06811324 — Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults · Phase 2 · recruiting
NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
NCT06897982 — Feasibility of a Nutrition Intervention for Patients With Prediabetes at a Federally Qualified Health Center · NA · recruiting
NCT06785064 — Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance · NA · recruiting
NCT06816147 — HealthyW8_60+ Pilot · NA · recruiting

Other Pennington Biomedical Research Center trials

Trials by the same sponsor.

NCT07530718 — Body Composition Outcomes in MS Patients · not yet recruiting
NCT07095972 — Continuous Glucose Monitoring in Metabolic Surgery · NA · not yet recruiting
NCT07139821 — Dietary Iron Requirements · recruiting
NCT07318064 — Ultra-processed Food Consumption and Health Pilot Study · NA · not yet recruiting
NCT07305753 — CanCan Body Composition Study · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06849206 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pennington Biomedical Research Center
Last refreshed: 17 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06849206.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing